Datamonitor, April 2002
1100, HIV Update 2002 (2) - February, Following Amgen?s $16 billion ... prospects demand robust, well diversified and highly competitive pipelines with clear ...
Business Insights, Aug 2007, Pages: 345
... ?Immunomodulators: Therapeutic Needs, Pipelines & Prospects ... However, the treatment of HIV and HCV infections has also warranted the development of therapeutic ...
Arrowhead Publishers, May 2007, Pages: 186
... According to our new report The Antivirals Market: R&D Pipelines, Markey Analysis and ... and the launch of ten new products for the treatment of HIV and hepatitis ...
Datamonitor, Sep 2004, Pages: 89
... of the prevalence of the co-morbid population in the seven major marketsIdentify the most promising products in the HIV and HBV pipelines, and track how ...
Decision Resources, Inc., March 2008, Pages: 39
... by the pharmaceutical industry to fill sparse pipelines with new ... CP-675,206 (Tremelimumab) Complement and Complement Receptor Antibodies HIV Antibody Therapies ...
Life Science Analytics, March 2008, Pages: 360
599523, Infections AIDS HIV, "Infections AIDS HIV " contains detailed information on the ... Report provides the user with real detail on drug pipelines, by company ...
Life Science Analytics, June 2007, Pages: 18
...HIV Drug Pipeline Report, Life Science Analytics, "Infections - AIDS HIV Drug Pipeline ... Report provides the user with real detail on drug pipelines, by company ...
Business Insights, Sep 2008, Pages: 253
... main areas of clinical need, general/proprietary technologies and company pipelines, and the ... of RNAi therapeutics 73 RNAi drugs in development 74 HIV virus 77 ...
Datamonitor, Dec 2005, Pages: 202
... starting to show greater interest in other therapeutic areas, from HIV and infectious ... Analyze and benchmark leading companies strategies and pipelines, as well ...
Mergent, Sep 2004, Pages: 32
... US$89.7 billion in 2003, reflecting robust drug development pipelines, ageing populations ... There are more than seven million inhabitants living with HIV/AIDS in ...
Datamonitor, May 2008, Pages: 93
... Figure 1: Ways to reposition drugs 9 Figure 2: Weak pipelines drive adoption ... drug development pipeline, 2008 46 Figure 17: Plerixafors action in HIV and stem ...
Global Markets Direct, Jan 2009, Pages: 37
... 9 2.3 Industry Outlook - In Vitro Diagnostics 9 2.4 Industry Outlook - Pipelines 10 3 ... Status 31 3.21.2 Product Description 31 3.22 Saliva-based HIV test 31 3.22 ...
Decision Resources, Inc., Dec 2007, Pages: 40
... in this class have a particularly difficult time breaking into the HIV market after ... prescription drugs in the world; the late-stage product pipelines of select ...
La Merie, Jan 2009, Pages: 41
... Anti-viral peptides are used to treat infections such as HIV and AIDS ... In addition, the report lists company-specific R&D pipelines of anti-infective peptides. ...
Global Markets Direct, Jan 2009, Pages: 14
... programs and R&D initiatives based on regulatory events of competitor product pipelines. ... 8 3.2.2 Product Description 8 3.3 Disease Staging Test for HIV 8 3.3.1 ...
Life Science Analytics, March 2009, Pages: 852
... Area Pipeline Report provides the user with real detail on drug pipelines, by company ... Projects Legend --Top 5 Companies in Early Stage AIDS/HIV Products --Top ...
Global Markets Direct, Jan 2009, Pages: 19
... programs and R&D initiatives based on regulatory events of competitor product pipelines. ... 05, 2008: OraSure Technologies To Sell OraQuick ADVANCE Rapid HIV-1/2 ...
Espicom Business Intelligence Ltd, Nov 2007, Pages: 614
... report examines the research investment and drug pipelines for 39 ... ANTIFUNGALS OPHTHALMOLOGICAL UROLOGY NEUROLOGY METABOLIC ONCOLOGY HIV OTHERS MITSUBISHI ...
Global Markets Direct, Aug 2008, Pages: 42
... programs and R&D initiatives based on regulatory events of competitor product pipelines. ... 12 Mar 07, 2006: New Test For Improved Detection Of HIV And Hepatitis ...
